Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1
Seeking Alpha
Saturday, April 6, 2013 - 11:01am
tags:
4 Healthcare Stock Stories for Weekend Investment Wellness
Wall Street Cheat Street
Saturday, April 6, 2013 - 11:00am
tags:
JNJ, Pfizer, Acura, Furiex Pharmaceuticals
Biogen Hits Primary Endpoints in MS Study
Motley Fool
Saturday, April 6, 2013 - 10:53am
tags:
Biogen, MS, multiple sclerosis, daclizumab
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation
Yahoo/BusinessWire
Saturday, April 6, 2013 - 10:52am
tags:
Incyte, lawsuits
Infinity Pharmaceuticals CEO Discusses Cancer Drugs (video)
Bloomberg
Saturday, April 6, 2013 - 10:51am
tags:
Infinity Pharmaceuticals
Cramer: Major Profit Potential in 2 Diagnostics
CNBC
Saturday, April 6, 2013 - 10:50am
tags:
OPKO, EXACT Sciences
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, April 6, 2013 - 10:49am
tags:
Rigel Pharmaceuticals, Achillion, Halozyme
Biogen Idec Inc (BIIB): Today's Featured Drugs Straggler
The Street
Saturday, April 6, 2013 - 10:48am
tags:
Biogen Idec
Cytokinetics Begins CK-2127107 Study
Yahoo/Zacks
Saturday, April 6, 2013 - 10:47am
tags:
Cytokinetics, CK-2127107
Obagi Bidding War Seen Pushing Premium to 99%: Real M&A
Bloomberg
Saturday, April 6, 2013 - 10:46am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, Merz
EP Vantage Interview - Bind Boosted By 2 Nanomedicine Deals
Seeking Alpha
Saturday, April 6, 2013 - 10:45am
tags:
Bind Therapeutics
IMS sees little drug spending impact from shift to managed Medicaid plans
Fierce Pharma
Friday, April 5, 2013 - 11:43am
tags:
IMS, Medicaid
India's top court rebuffs Merck, lets generic Januvia roll out
Fierce Pharma
Friday, April 5, 2013 - 11:42am
tags:
India, Merck, Januvia, diabetes, generics, Glenmark
Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
Yahoo
Friday, April 5, 2013 - 11:41am
tags:
Neuralstem, patents, stem cells, ALS, Lou Gehrig's disease
Defibrillator lawsuit could re-expose device makers to litigation: WSJ
Marketwatch
Friday, April 5, 2013 - 11:15am
tags:
defibrillators, devices, St. Jude Medical, Medtronic, Boston Scientific
Clawing Back Money From Pharma Execs Over Bad Behavior
Pharmalot
Friday, April 5, 2013 - 11:13am
tags:
executive pay
Astex Pharmaceuticals: A Catalyst-Driven Year Ahead
Seeking Alpha
Friday, April 5, 2013 - 11:11am
tags:
Astex, SG-110, Celgene
Orphan Status for Insmed's Arikace
Yahoo/Zacks
Friday, April 5, 2013 - 11:10am
tags:
Arikace, orphan drugs, Insmed, non-tuberculous mycobacteria
Obagi Bidding War Seen Pushing Premium to 99%: Real M&A
Bloomberg
Friday, April 5, 2013 - 11:08am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, Merz, M&A
Positive Data on Repros' Androxal
Yahoo/Zacks
Friday, April 5, 2013 - 11:07am
tags:
Repros Therapeutics, Androxal, secondary hypogonadism

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.